CLBT (Cellebrite DI) Other Current Payables: $79.7 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CLBT Cellebrite DI Ltd CLBT
89 GF Score
Price $10.15
GF Value $16.08
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Cellebrite DI Other Current Payables?

Cellebrite DI CLBT -33.47% 89 Other Current Payables is $79.7 Mil as of Mar. 2026. GuruFocus rates CLBT with a GF Score™ of 89/100 and a GF Value™ of $16.08 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Cellebrite DI's Other Current Payables for the quarter that ended in Mar. 2026 was $79.7 Mil.

Cellebrite DI's quarterly Other Current Payables declined from Sep. 2025 ($62.5 Mil) to Dec. 2025 ($6.6 Mil) but then increased from Dec. 2025 ($6.6 Mil) to Mar. 2026 ($79.7 Mil).

Cellebrite DI's annual Other Current Payables increased from Dec. 2023 ($2.9 Mil) to Dec. 2024 ($5.3 Mil) and increased from Dec. 2024 ($5.3 Mil) to Dec. 2025 ($6.6 Mil).

Cellebrite DI Other Current Payables Related Terms

Cellebrite DI Other Current Payables Historical Data

* Premium members only.

The historical data trend for Cellebrite DI's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cellebrite DI Other Current Payables Chart

Cellebrite DI Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Payables
Get a 7-Day Free Trial 2.59 2.23 2.88 5.32 6.59

Cellebrite DI Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 53.93 67.97 62.49 6.59 79.65
CLBT
89GF Score
Cellebrite DI Ltd CLBT
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cellebrite DI Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of $79.7 Mil mean?
Cellebrite DI (CLBT) has a Other Current Payables of $79.7 Mil as of Mar. 2026. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Cellebrite DI and its competitors.
Is Cellebrite DI's Other Current Payables too high?
Cellebrite DI's current Other Current Payables is $79.7 Mil. Overall, Cellebrite DI has a GF Score™ of 89/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cellebrite DI's Other Current Payables compare to TENB and PAY?
Cellebrite DI's Other Current Payables of $79.7 Mil can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Software company?
A good Other Current Payables depends on the Software industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Cellebrite DI and its competitors. Cellebrite DI's current Other Current Payables is $79.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cellebrite DI stock overvalued right now?
Based on GuruFocus' analysis, Cellebrite DI (CLBT) is currently considered Significantly Undervalued. The stock's GF Value™ is $16.08, compared to a current price of $10.15 — trading 36.9% below its estimated fair value. The current Other Current Payables is $79.7 Mil. Cellebrite DI's overall GF Score™ is 89/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Cellebrite DI (CLBT), the current Other Current Payables is $79.7 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cellebrite DI (CLBT) Overvalued in 2026?

Based on GuruFocus' analysis, Cellebrite DI stock appears to be undervalued. The current stock price of $10.15 is trading 36.9% below its estimated GF Value™ of $16.08. GuruFocus considers Cellebrite DI to be Significantly Undervalued.

Key valuation signals for CLBT:

  • Other Current Payables: $79.7 Mil
  • GF Value™: $16.08 vs. price of $10.15 (36.9% below fair value)
  • GF Score™: 89/100 with 3 warning signs

No single metric tells the full story. See the CLBT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cellebrite DI Business Description

Other Exchanges 9W9:Germany
Address 94 Shlomo Shmelzer Road, P.O. Box 3925, Petah Tikva, ISR, 4970602
Cellebrite DI Ltd provides AI-powered digital investigative and intelligence solutions that help public and private sector customers transform investigative workflows, make digital data more accessible and actionable, and improve the efficiency of mobile research and application security. Its solutions support law enforcement, defense, and intelligence agencies in advancing investigations, border security, counterterrorism, intelligence operations, and cyber operations. The company's software also enables enterprises and service providers to collect and review data for corporate investigations, eDiscovery, incident response, and mobile application validation. It operates in the Americas, APAC, and EMEA, with the majority of revenue from the Americas.
89GF Score

Get the complete analysis for CLBT

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.15
Price
$16.08
GF Value